Beschreibung:
The TNM Supplement, 4th Edition, includes new, detailed definitions of anatomical sites, regional lymph nodes, and TNM categories. It answers questions that frequently arise during daily use of the TNM system. Importantly, the TNM Supplement expands on the minimum requirements for pathological classification of individal tumour sites and enumerates the recommended criteria for each. Published in association with the Union for International Cancer Control, it provides oncologists with complementary material related to TNM staging not covered in TNM Classification of Malignant Tumours, 7th Edition.
The TNM Supplement, 4th Edition, includes new, detailed definitions of anatomical sites, regional lymph nodes, and TNM categories. It answers questions that frequently arise during daily use of the TNM system. Importantly, the TNM Supplement expands on the minimum requirements for pathological classification of individal tumour sites and enumerates the recommended criteria for each. Published in association with the Union for International Cancer Control, it provides oncologists with complementary material related to TNM staging not covered in TNM Classification of Malignant Tumours, 7th Edition.
Preface, viii
Organizations Associated with the TNM System, xiii
National Committees, xiii
Acknowledgements, xiv
Abbreviations, xv
Chapter 1 EXPLANATORY NOTES - GENERAL
The General Rules of the TNM System, 1
The TNM Clinical and Pathological Classifications, 6
Residual Tumour (R) Classification, 14
Additional Descriptors, 18
Unknown Primary, 22
Staging of Tumours for Which No TNM Classification is Provided,22
Histopathological Grading, 23
Chapter 2 EXPLANATORY NOTES - SPECIFIC ANATOMICALSITES
Head and Neck Tumours, 30
Lip and Oral Cavity, 37
Digestive System Tumours, 46
Lung and Pleural Tumours, 69
Bone Tumours, 81
Soft Tissue Tumours, 82
Skin Tumours, 83
Breast Tumours, 89
Gynaecological Tumours, 92
Urological Tumours, 101
Kidney, 105
Adrenal Cortex Tumours 109
Ophthalmic Tumours 110
Hodgkin Lymphoma and Non-Hodgkin Lymphomas, 116
Appendix, 118
Chapter 3 SITE-SPECIFIC REQUIREMENTS FOR pT AND pN
Introduction, 134
Head and Neck Tumours, 136
Digestive System Tumours, 142
Lung and Pleural Tumours, 148
Tumours of Bone and Soft Tissues, 150
Skin Tumours, 151
Breast Tumours, 154
Gynaecological Tumours, 156
Urological Tumours, 159
Adrenal Cortex Tumours, 164
Ophthalmic Tumours, 165
Hodgkin Lymphoma and Non-Hodgkin Lymphomas, 167
Chapter 4 NEW TNM CLASSIFICATIONS RECOMMENDED FORTESTING
Introduction, 171
General, 171
Specific, 171
Gastrointestinal Sarcomas (other than GISTs) (ICD-O C15-21),172
Malignant Thymic Epithelial Tumours (Thymoma) (ICD-O C37),174
Cranial and Facial Bones (ICD-O C41.0, 1), 174
Primary Cutaneous Lymphomas, 177
Cutaneous T-Cell Lymphoma (Excluding Lip, Eyelid, Vulva andPenis) (ICD-0 C44.2-7, C63.2), 177
ISLC/EORTC Revision to the Classification of Mycosis Fungoidesand Sézary Syndrome, 180
Chronic Myeloid Leukaemia, 182
Multiple Myeloma, 185
Primary Liver Carcinoma in Infants and Children/Hepatoblastoma,186
Adrenal Cortex Carcinoma, 188
Liver Metastasis of Colorectal Carcinoma, 188
Gastrointestinal Malignant Lymphomas, 189
Chapter 5 OPTIONAL PROPOSALS FOR TESTING NEW TELESCOPICRAMIFICATIONS OF TNM
All Tumour Sites, 193
Head and Neck Tumours, 193
Digestive System Tumours, 193
Liver, 196
Lung Tumours, 196
Tumours of Bone and Soft Tissues, 198
Gynaecological Tumours, 198
Urological Tumours, 199
Chapter 6 FREQUENTLY ASKED QUESTIONS
General Questions, 202
Site-Specific Questions, 211
Index, 243
Plate section facing p. 48